Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | PPARA | Q07869 | 4/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23779944 | 0.83 | CHRM1 (0.46) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5859582 | 0.83 | CHRM1 (0.46) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL17323727 | 0.80 | TSHR (0.40) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL23779934 | 0.77 | TSHR (0.37) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL23779935 | 0.77 | TSHR (0.37) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL7192903 | 0.76 | CHRM1 (0.35) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5744404 | 0.75 | TSHR (0.36) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL15945448 | 0.75 | CA1 (0.42) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL28046131 | 0.73 | TSHR (0.34) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL933721 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010096382-A1 | PROCESSES FOR THE PRODUCTION OF PROTEINS CONTAINING SELENIUM USING YEAST CELLS | NOVUS INTERNATIONAL INC. (US) | 2010-08-26 | — | — | WO | claimed |
| EP-1778706-B1 | NEW SELENOHYDROXY ACIDS AND THEIR DERIVATIVES: APPLICATIONS IN NUTRITION, COSMETICS AND PHARMACEUTICS | TETRAHEDRON (FR) | 2009-07-08 | — | — | EP | disclosed |
| US-7381416-B2 | Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics | TETRAHEDRON SAS (FR) | 2008-06-03 | — | — | US | disclosed |
| EP-1778706-A2 | NEW SELENOHYDROXY ACIDS AND THEIR DERIVATIVES APPLICATIONS IN NUTRITION, COSMETICS AND PHARMACEUTICS | Tetrahedron (FR) | 2007-05-02 | — | — | EP | disclosed |
| US-20060105960-A1 | New selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics | TETRAHEDRON SAS (FR) | 2006-05-18 | — | — | US | disclosed |
| WO-2006008190-A2 | SELENOHYDROXY ACIDS AND THEIR DERIVATIVES, APPLICATIONS IN NUTRITION, COSMETICS AND PHARMACEUTICS | TETRAHEDRON (FR) | 2006-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060105960-A1 | New selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics | SPTLC3, SGMS2, SGMS1 | CHRM1 873/4885AKR1A1 396/4885CHRM3 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.